Skip to main content

Table 5 Logistic regression analyses for 38G and CAPRA-S for association with patient outcome (TCGA cohort)

From: A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence

 

Odds ratio

2.50%

97.50%

p-value

Univariate

 38G

7.99

2.28

50.66

5.65E-03

 CAPRA-S

2.99

1.68

5.72

4.18E-04

Multivariate

 38G

5.7

1.57

36.66

2.26E-02

 CAPRA-S

2.5

1.39

4.85

3.65E-03

  1. Note: CAPRA-S has been assessed as per categorical risk classification: low, intermediate, and high-risk
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us